Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Barr granted approval for generic Parkinson’s drug
The company’s pramipexole dihydrochloride is a generic version to Boehringer Ingelheim’s Mirapex tablets. The company is currently challenging a patent protecting Mirapex and a trial is scheduled to
The company’s pramipexole dihydrochloride is a generic version to Boehringer Ingelheim’s Mirapex tablets. The company is currently challenging a patent protecting Mirapex and a trial is scheduled to
Under the terms of the agreement, Martek will serve as Numico’s exclusive supplier for all of its ARA (arachidonic acid) and microbially-derived DHA (docosahexaenoic acid) needs for infant
This trial is claimed to be the company’s first clinical trial to take place in the US and denotes the commencement of the company’s planned expansion into targeted,
The cooperation will evaluate the ability of the Lex System to improve therapeutic profiles through optimization of antibody glycosylation structures. Jan Turek, President and CEO of Biolex, said:
Following the acquisition company has changed its name from Beijing Med-Pharm Corporation to BMP Sunstone Corporation. David Gao, CEO of BMP Sunstone, said: “With today’s announcement, we immediately
In the study, CBLB502 was injected 30 minutes before cisplatinum at a dose of 1mcg/mouse (0.04mg/kg, which is less than 1% of maximal tolerable dose). Cisplatinum was injected
The milestone payment has been triggered by Ophthotech’s enrollment of the first volunteer in a Phase I study of E10030, an anti-platelet derived growth factor aptamer which is
PNIR will develop and commercialize a therapeutic product for peripheral nerve injury based on Cyberkinetics’s Andara Oscillating Field Stimulator (OFS) neurostimulation technology platform. Each company will have equal
The agreement, which is scheduled to take effect on June 1, 2008, grants Pinnacle Biologics exclusive Ethyol or amifostine marketing authorization, certain licenses and distribution rights in Western
The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the primary basis of an efficacy claim in support of a new drug